Masimo Corporation - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
MASI Nasdaq 3845 http://www.masimo.com/ 84.98 Stock Up +0.07

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Masimo Corporation

Here's Why Investors Should Buy Masimo (MASI) Right Now - Sep 22nd, 2017 6:38 am
The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew - Sep 22nd, 2017 5:21 am
Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy - Sep 20th, 2017 9:58 am
Masimo (MASI) Launches Rad-97 CO-Oximeter Post FDA Clearance - Sep 19th, 2017 6:07 am
See what the IHS Markit Score report has to say about Masimo Corp. - Sep 19th, 2017 6:05 am
​Masimo gets FDA clearance for its patient monitoring system - Sep 18th, 2017 2:20 pm
Masimo Announces FDA Clearance and Full Market Release of Rad-97™ Pulse CO-Oximeter® - Sep 18th, 2017 6:00 am
Newborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000 Health Workers through Newborn Screening Initiative in Support of Every Woman Every Child - Sep 14th, 2017 6:00 am
5 Discounted MedTech Stocks for a Healthy Portfolio - Sep 12th, 2017 7:57 am
Masimo Corporation Fell 12.7% in August -- but Why? - Sep 11th, 2017 3:06 pm
Masimo to Present at 15th Annual Morgan Stanley Global Healthcare Conference - Sep 6th, 2017 7:00 am
Why Is Masimo (MASI) Down 1.5% Since the Last Earnings Report? - Sep 6th, 2017 2:55 am
Ride Out MedTech Volatility With These 3 Ultra-Safe Stocks - Sep 5th, 2017 7:57 am
Study Evaluates Performance of Masimo iSpO2® Rx Smart Device-Paired Pulse Oximeter in Screening Newborns for Critical Congenital Heart Disease - Sep 5th, 2017 12:00 am
3 Excellent Value Picks as Political Chaos Grips MedTech - Aug 31st, 2017 2:57 pm
Here's Why Chemed (CHE) is a Suitable Growth Pick for Now - Aug 28th, 2017 7:36 am
Study Evaluates Utility of Masimo SpHb® During High-Blood-Loss Oncosurgery - Aug 28th, 2017 12:00 am